MMP14 and ovarian carcinoma: Computational analysis of a previously identified antigenic mimotope recognized by fingerprinting human autoantibodies from ovarian cancer patients [3] with more than two decades of accumulated biomedical data supports MMP14 and other MMPs as potential targets for discovery and development of translational theranostics.